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Background: For some geriatric patients with severe aortic stenosis (AS), symptoms are subjective and minimal, leading to decision change after 
the progression of disease and delay of optimal timing of aortic valve replacement (AVR) in patients who initially refused AVR. Only limited data on 
the prognosis in such patients are available.
Methods: The long-term survival of 108 patients referred for AVR with symptomatic severe AS between 2004 and 2008 was analyzed. Patients were 
divided into three categories according to the initial decision for AVR: subjects agreeing and undergoing AVR (group A, n=48); patients who initially 
refused AVR followed by decision change toward AVR due to worsening symptoms (group B, n=19) and those declined AVR throughout (group C, 
n=41).
Results: Elderly patients were more prevalent in Group B and C, compared with Group A (p<0.001). During a mean follow-up of 26 months, 
nineteen (32%) of patients initially refused AVR changed the decision toward AVR. However, seven (37%) of them died due to heart failure during 
waiting period before AVR. Kaplan-Meier survival at 3 years was 57±13% for group B, compared with 95±4% for group A and 48±10% for group C 
(p<0.001). Comparing subjects undergoing AVR in Group B with Group A, no significant difference was demonstrated regarding long-term prognosis. 
In multivariable analysis, decision change [HR=4.0, 95% CI (1.11-14.6), P=0.035], renal insufficiency [HR=3.3, 95% CI (1.17-9.02), P=0.024], and 
older age [hazard ratio (HR) =1.06, 95% CI (1.01-1.12)], P=0.030] were associated with mortality.
Conclusions: The initial patient’s decision might be crucial. The prognosis of subjects with severe AS who initially refused surgery is not benign and 
that survival is dramatically improved by AVR. These findings have significant implications for informed decision-making when managing AS patients.
